The Efficacy and Safety of Intralesional Candida Vaccine Versus Topical Diphencyproprobenone in Immunotherapy of Verruca Vulgaris: A Randomized Comparative Study

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 2022 Oct 16

PMID 36245011

Authors

Mohamed H M El-Komy

Shahenda Gamal Shamma

Nermeen Ibrahim Bedair

Affiliations

Soon will be listed here.

Abstract

Various therapeutic options are available for verruca. While physical destruction may be associated with scarring, immunotherapy may be effective in treating warts through stimulating body immune response. The objective of the study was to compare the efficacy, safety, and outcome of Candida antigen vs diphencyprone (DPCP) in the treatment of warts. Fifty patients were randomly assigned to receive either intralesional Candida antigen every 3 weeks or weekly DPCP application. Both treatments were applied only to the mother wart. Lesions' clearance and associated side effects were observed up to 4 weeks after treatment. Two blinded physicians evaluated photos of warts before and 4 weeks after the end of treatment. Both modalities granted wart clearance and/or improvement with no statistically significant difference; however, Candida antigen was significantly better in clearing adjacent untreated warts (p = 0.046). Fewer side effects were observed among the Candida antigen group. The response was duration associated in the Candida groups only. Intralesional Candida antigen injection and DPCP treatments for warts yielded improvement with superiority of Candida injection in eradicating distant lesions and fewer side effects. A shorter wart duration may be associated with a better therapeutic response with Candida antigen.

Citing Articles

Vaccines in Dermatology-Present and Future: A Review.

Goh E, Chavatte J, Lin R, Ng L, Renia L, Oon H Vaccines (Basel). 2025; 13(2).

PMID: 40006672 PMC: 11860801. DOI: 10.3390/vaccines13020125.

References

Rampen F, Steijlen P . Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Dermatology. 1996; 193(3):236-8. DOI: 10.1159/000246252. View

Suh D, Lew B, Sim W . Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts. Int J Dermatol. 2014; 53(12):e567-71. DOI: 10.1111/ijd.12688. View

Nassar A, Mostafa M, Khashaba S . Photodynamic therapy versus candida antigen immunotherapy in plane wart treatment: a comparative controlled study. Photodiagnosis Photodyn Ther. 2020; 32:101973. DOI: 10.1016/j.pdpdt.2020.101973. View

Nofal A, Yehia E, Khater E, Bessar H . Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts. J Am Acad Dermatol. 2020; 83(1):208-210. DOI: 10.1016/j.jaad.2020.01.054. View

Sinha S, Relhan V, Garg V . Immunomodulators in warts: Unexplored or ineffective?. Indian J Dermatol. 2015; 60(2):118-29. PMC: 4372902. DOI: 10.4103/0019-5154.152502. View

Marei A, Alakad R, Wahid R . Evaluation of intralesional Candida antigen in diabetic patients with multiple warts. J Cosmet Dermatol. 2020; 20(4):1248-1253. DOI: 10.1111/jocd.13718. View

Nofal A, El-Arab R, Nasr M, Alakad R . Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional Antigen in the Treatment of Common and Plantar Warts. J Cutan Med Surg. 2021; 25(4):377-383. DOI: 10.1177/1203475421991130. View

Clifton M, Johnson S, Roberson P, Kincannon J, Horn T . Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol. 2003; 20(3):268-71. DOI: 10.1046/j.1525-1470.2003.20318.x. View

Buckley D, Du Vivier A . The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol. 2001; 145(3):385-405. DOI: 10.1046/j.1365-2133.2001.04399.x. View

10.

Hammad N, Abdelhadi A, Fawzy M, Marei A . Complement component 3c and tumor necrosis factor-α systemic assessment after Candida antigen immunotherapy in cutaneous warts. Braz J Microbiol. 2020; 51(4):1673-1681. PMC: 7688774. DOI: 10.1007/s42770-020-00322-0. View

11.

Park H, Choi Y, Kim S, Shin M, Lee S, Oh M . Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester. Clin Exp Dermatol. 2013; 38(7):775-81. DOI: 10.1111/ced.12075. View

12.

Kim K, Horn T, Pharis J, Kincannon J, Jones R, OBryan K . Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts. Arch Dermatol. 2010; 146(12):1431-3. DOI: 10.1001/archdermatol.2010.350. View

13.

Orecchia G, Douville H, Santagostino L, Rabbiosi G . Treatment of multiple relapsing warts with diphenciprone. Dermatologica. 1988; 177(4):225-31. DOI: 10.1159/000248568. View

14.

Hodeib A, Al-Sharkawy B, Hegab D, Talaat R . A comparative study of intralesional injection of antigen, bleomycin and 5-fluorouracil for treatment of plane warts. J Dermatolog Treat. 2019; 32(6):663-668. DOI: 10.1080/09546634.2019.1688236. View

15.

Signore R . Candida albicans intralesional injection immunotherapy of warts. Cutis. 2002; 70(3):185-92. View

16.

van der Steen P, van de Kerkhof P, der Kinderen D, van Vlijmen I, Happle R . Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone. J Dermatol. 1991; 18(6):330-3. DOI: 10.1111/j.1346-8138.1991.tb03093.x. View

17.

Fathy G, Sharara M, Khafagy A . Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study. Dermatol Ther. 2019; 32(5):e12997. DOI: 10.1111/dth.12997. View

18.

Pollock B, Highet A . An interesting response to diphencyprone (DPC) sensitization on facial warts: review of DPC treatment for viral warts. J Dermatolog Treat. 2002; 13(2):47-50. DOI: 10.1080/095466302317584386. View

19.

Majid I, Imran S . Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study. Indian J Dermatol. 2013; 58(5):360-5. PMC: 3778775. DOI: 10.4103/0019-5154.117301. View

20.

Nofal A, Albalat W, Ismail A, Khattab F . Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study. J Dermatolog Treat. 2020; 33(2):922-927. DOI: 10.1080/09546634.2020.1789540. View